0,854  0,005  Caspase 9 stimulant
0,808  0,014  Antiinflammatory
0,769  0,020  Apoptosis agonist
0,742  0,007  Sensitization
0,703  0,004  UGT1A4 substrate
0,642  0,014  Antihypercholesterolemic
0,629  0,021  TNF expression inhibitor
0,615  0,009  Antipruritic, allergic
0,624  0,031  Antineoplastic (breast cancer)
0,602  0,030  Antineoplastic (lung cancer)
0,576  0,013  Antineoplastic (pancreatic cancer)
0,535  0,007  UGT2B4 substrate
0,538  0,017  Hepatic disorders treatment
0,536  0,016  Lipoprotein disorders treatment
0,509  0,006  Prostatic (benign) hyperplasia treatment
0,530  0,031  CYP2C9 substrate
0,523  0,024  Bone diseases treatment
0,537  0,039  Transcription factor NF kappa B inhibitor
0,499  0,004  Antiinfertility, female
0,498  0,005  UGT2B7 substrate
0,510  0,019  Antipsoriatic
0,519  0,030  Cholesterol antagonist
0,503  0,016  Nitric oxide antagonist
0,496  0,010  Antihypoxic
0,488  0,005  Prostate disorders treatment
0,488  0,012  Antineoplastic (endocrine cancer)
0,491  0,016  Antipyretic
0,480  0,007  Contraceptive
0,511  0,038  Antileukemic
0,492  0,021  NOS3 expression inhibitor
0,491  0,021  Antiosteoporotic
0,491  0,022  AR expression inhibitor
0,501  0,032  Prostate cancer treatment
0,495  0,028  CYP2C19 substrate
0,506  0,040  CYP3A4 substrate
0,475  0,012  Antineoplastic (liver cancer)
0,483  0,022  UGT1A9 substrate
0,467  0,012  UGT1A1 substrate
0,461  0,007  Antiacne
0,474  0,021  Chemopreventive
0,457  0,005  Antipruritic, non-allergic
0,459  0,011  Anesthetic general
0,464  0,016  Hypolipemic
0,461  0,016  UGT1A6 substrate
0,453  0,009  Hair growth stimulant
0,451  0,009  UGT1A3 substrate
0,470  0,031  Antineoplastic (ovarian cancer)
0,461  0,023  Cardiovascular analeptic
0,491  0,053  Cyclophilin D inhibitor
0,491  0,053  Antidiabetic
0,437  0,004  UGT2B9 substrate
0,431  0,004  Contraceptive female
0,429  0,011  Antiparkinsonian, rigidity relieving
0,410  0,004  TRPA1 agonist
0,418  0,013  Abortion inducer
0,411  0,008  UGT2B15 substrate
0,416  0,013  Sodium/bile acid cotransporter inhibitor
0,440  0,037  Respiratory analeptic
0,452  0,049  Antiobesity
0,443  0,048  Atherosclerosis treatment
0,414  0,020  Calcium channel activator
0,396  0,006  Neurotrophic factor enhancer
0,395  0,005  Gastrin inhibitor
0,401  0,012  Anesthetic
0,392  0,004  ABCA1 expression enhancer
0,391  0,011  Interferon gamma antagonist
0,400  0,032  NOS2 expression inhibitor
0,402  0,034  Chemoprotective
0,390  0,023  Sigma receptor agonist
0,377  0,011  Lipocortins synthesis antagonist
0,403  0,040  Antineoplastic (melanoma)
0,404  0,043  Caspase 3 stimulant
0,365  0,006  Cholesterol synthesis inhibitor
0,413  0,058  Immunosuppressant
0,375  0,023  UDP-glucuronosyltransferase substrate
0,404  0,054  Vasodilator, peripheral
0,357  0,010  Antiviral (Influenza A)
0,384  0,043  Apoptosis antagonist
0,383  0,047  ICAM1 expression inhibitor
0,345  0,010  Interleukin 6 antagonist
0,358  0,026  Antineoplastic enhancer
0,332  0,005  Retinoprotector
0,333  0,012  Antiparkinsonian, tremor relieving
0,366  0,046  Analeptic
0,341  0,025  Growth hormone agonist
0,384  0,071  CYP2C19 inhibitor
0,334  0,022  Non-steroidal antiinflammatory agent
0,333  0,022  Antiviral (Influenza)
0,333  0,025  Antihelmintic
0,330  0,023  Hepatoprotectant
0,352  0,045  Antineoplastic (cervical cancer)
0,347  0,043  Antineoplastic (multiple myeloma)
0,336  0,035  Antiparasitic
0,344  0,044  Cytotoxic
0,299  0,005  Potassium channel (Ca-activated) activator
0,365  0,075  Ulceration
0,318  0,028  Muscle relaxant
0,298  0,008  LDLR expression enhancer
0,341  0,053  Teratogen
0,290  0,005  HDL-cholesterol increasing
0,333  0,049  Antidiabetic (type 2)
0,343  0,060  CYP2D6 substrate
0,288  0,006  SULT1A1 substrate
0,293  0,010  Endometrios treatment
0,331  0,053  Embryotoxic
0,278  0,003  Liver X receptor alpha agonist
0,315  0,044  Vascular (periferal) disease treatment
0,322  0,052  Antineoplastic (glioma)
0,274  0,005  Potassium channel large-conductance Ca-activated activator
0,273  0,005  Aromatase inhibitor
0,333  0,067  Antifungal
0,336  0,070  Antineoplastic (colorectal cancer)
0,274  0,008  UGT2B10 substrate
0,274  0,008  Farnesoid X receptor antagonist
0,305  0,042  Antiulcerative
0,271  0,014  Antifungal enhancer
0,324  0,068  Antineoplastic (colon cancer)
0,305  0,051  Proliferative diseases treatment
0,280  0,026  Diuretic
0,258  0,004  5-Alpha-reductase inhibitor
0,257  0,009  Androgen antagonist
0,258  0,011  Nav1.1 sodium channel blocker
0,254  0,010  UGT2B1 substrate
0,303  0,060  Antioxidant
0,242  0,005  Pregnane X receptor agonist
0,303  0,070  CTGF expression inhibitor
0,247  0,013  Sulfotransferase substrate
0,237  0,004  Glutamate release inhibitor
0,301  0,069  5 Hydroxytryptamine release stimulant
0,239  0,008  Arachidonic acid antagonist
0,253  0,025  CNS active muscle relaxant
0,232  0,004  Antiviral (Coronavirus)
0,232  0,004  Antiviral (SARS coronavirus)
0,281  0,060  Antiprotozoal (Leishmania)
0,240  0,020  Adenylate cyclase inhibitor
0,239  0,020  Antihyperlipoproteinemic
0,291  0,074  Spasmolytic
0,291  0,075  Cardioprotectant
0,255  0,042  Antialcoholic
0,272  0,060  Acute neurologic disorders treatment
0,217  0,008  Actinic keratosis treatment
0,241  0,033  Protein-tyrosine phosphatase inhibitor
0,282  0,075  Hypoxia-inducible factor 1 alpha inhibitor
0,282  0,077  CYP1A2 substrate
0,258  0,053  Antihypertriglyceridemic
0,266  0,062  Cardiodepressant
0,306  0,102  Stroke treatment
0,225  0,022  Protein-tyrosine phosphatase 1B inhibitor
0,227  0,026  Nav1.2 sodium channel blocker
0,226  0,025  Insulin secretagoues
0,209  0,010  Adenylate cyclase stimulant
0,284  0,086  Interleukin 2 agonist
0,230  0,032  Antipruritic
0,248  0,050  Sedative
0,204  0,006  CDC25A inhibitor
0,226  0,028  Toxic, respiratory center
0,314  0,117  Histamine release inhibitor
0,265  0,068  Tumour necrosis factor alpha release inhibitor
0,252  0,058  Psychostimulant
0,226  0,034  Skeletal muscle relaxant
0,213  0,025  SULT1A3 substrate
0,192  0,005  Ornithine decarboxylase inhibitor
0,203  0,016  Menstruation disorders treatment
0,210  0,025  Psychosexual dysfunction treatment
0,219  0,034  Phospholipase A2 inhibitor
0,257  0,073  Hypoglycemic
0,218  0,036  Protein kinase stimulant
0,185  0,003  Liver X receptor alpha antagonist
0,191  0,009  Keratolytic
0,185  0,005  Acetyl-CoA transferase inhibitor
0,266  0,089  Antiepileptic
0,338  0,165  Ca2+/calmodulin-dependent protein kinase kinase A inhibitor
0,271  0,098  CYP3A4 inhibitor
0,192  0,019  Anticataract
0,308  0,136  Analgesic
0,264  0,095  Metabolic disease treatment
0,173  0,004  Aldosterone antagonist
0,199  0,031  Cocaine dependence treatment
0,210  0,043  VEGF expression inhibitor
0,168  0,003  Retinoid X alpha receptor agonist
0,170  0,005  Bile acid receptor antagonist
0,208  0,044  Antiviral (Herpes)
0,212  0,049  Diabetic nephropathy treatment
0,171  0,009  Tocolytic
0,170  0,009  UGT2B11 substrate
0,163  0,002  Heme oxygenase stimulant
0,165  0,004  Liver X receptor antagonist
0,165  0,005  11-Beta-hydroxysteroid dehydrogenase 1 inhibitor
0,164  0,005  Progesterone antagonist
0,165  0,007  3C-Like protease (SARS coronavirus) inhibitor
0,243  0,084  DNA damaging
0,163  0,005  Cushing's syndrome treatment
0,221  0,063  Carcinogenic
0,158  0,003  Liver X receptor beta antagonist
0,157  0,002  Cholesterol ester transfer protein antagonist
0,246  0,092  Renal disease treatment
0,211  0,057  P-glycoprotein inhibitor
0,163  0,012  Anabolic
0,153  0,005  Liver X receptor agonist
0,151  0,004  Liver X receptor beta agonist
0,266  0,119  Vasodilator, coronary
0,236  0,090  Interleukin agonist
0,148  0,003  Retinoid X receptor agonist
0,190  0,045  Melanin inhibitor
0,150  0,006  SULT1A2 substrate
0,148  0,007  Glycine receptor agonist
0,254  0,114  Antineoplastic (brain cancer)
0,177  0,036  DNA polymerase I inhibitor
0,151  0,011  Estrogen agonist
0,217  0,077  RNA-directed DNA polymerase inhibitor
0,150  0,011  Lanosterol 14 alpha demethylase inhibitor
0,234  0,097  Transcription factor STAT3 inhibitor
0,235  0,098  Transcription factor STAT inhibitor
0,152  0,015  Inducible nitric-oxide synthase inhibitor
0,167  0,031  Growth stimulant
0,168  0,033  Autism spectrum disorders treatment
0,146  0,012  Estrogen receptor alpha antagonist
0,153  0,021  Prolactin inhibitor
0,179  0,051  Lipid peroxidase inhibitor
0,241  0,114  12-Lipoxygenase inhibitor
0,178  0,051  NOS3 expression enhancer
0,164  0,038  Cyclooxygenase 3 inhibitor
0,214  0,088  Angiogenesis stimulant
0,181  0,057  Phobic disorders treatment
0,229  0,105  5 Hydroxytryptamine uptake stimulant
0,148  0,024  Estrogen antagonist
0,131  0,008  Anticholelithogenic
0,153  0,031  Choleretic
0,138  0,019  Transcription factor NF kappa B stimulant
0,130  0,011  Na+ K+ transporting ATPase inhibitor
0,135  0,018  Contraceptive male
0,185  0,068  Male reproductive disfunction treatment
0,161  0,044  Anesthetic local
0,136  0,021  Paget's disease treatment
0,148  0,034  Alcohol dehydrogenase substrate
0,125  0,013  Hyperparathyroidism treatment
0,121  0,010  Cannabinoid CB2 receptor antagonist
0,176  0,065  Phospholipase C inhibitor
0,115  0,004  Steroid 17-alpha-hydroxylase/17,20 lyase inhibitor
0,114  0,005  5-Alpha-reductase 2 inhibitor
0,168  0,060  Acute respiratory distress syndrome (ARDS) treatment
0,148  0,041  Vanilloid 1 agonist
0,172  0,067  Antihelmintic (Nematodes)
0,108  0,004  5-Alpha-reductase 1 inhibitor
0,107  0,004  Adenylate cyclase 1 inhibitor
0,121  0,018  Glycine receptor antagonist
0,107  0,005  Postcoital contraceptive
0,114  0,013  Estrogen-related receptor beta agonist
0,187  0,087  Insulin sensitizer
0,132  0,031  Nitric-oxide synthase inhibitor
0,111  0,012  Androgen agonist
0,108  0,009  3(or 17)beta-hydroxysteroid dehydrogenase inhibitor
0,179  0,082  Wound healing agent
0,235  0,139  Antithrombotic
0,125  0,030  Potassium channel activator
0,098  0,004  Geranyltranstransferase inhibitor
0,173  0,079  Antirickettsial
0,098  0,004  11-Beta-hydroxysteroid dehydrogenase 2 inhibitor
0,097  0,004  Retinoid X gamma receptor agonist
0,254  0,161  15-Lipoxygenase inhibitor
0,122  0,030  Estrogen receptor beta antagonist
0,095  0,003  Alpha 1L adrenoreceptor agonist
0,147  0,057  Nav1.6 sodium channel blocker
0,096  0,006  Calcium channel P-type blocker
0,092  0,005  Cholesterol esterase inhibitor
0,100  0,014  Uterine relaxant
0,089  0,005  Acetyl-CoA transferase 1 inhibitor
0,089  0,005  Glucocorticoid antagonist
0,110  0,028  Opioid kappa receptor antagonist
0,087  0,005  Farnesoid X receptor agonist
0,088  0,007  RNA-directed RNA polymerase stimulant
0,104  0,025  Lipase inhibitor
0,097  0,018  Postmenopausal disorders treatment
0,135  0,056  Antiviral (Hepatitis B)
0,119  0,041  Hedgehog signaling inhibitor
0,080  0,003  Retinoid X receptor antagonist
0,085  0,009  Acetyl-CoA transferase 2 inhibitor
0,157  0,082  Muscular dystrophy treatment
0,089  0,015  SULT2A1 substrate
0,198  0,124  Radioprotector
0,183  0,110  Antineoplastic (lymphoma)
0,092  0,019  CDC25B inhibitor
0,190  0,118  Antineoplastic (renal cancer)
0,147  0,074  Acaricide
0,222  0,151  Antineoplastic (osteosarcoma)
0,221  0,149  GST M1-1 substrate
0,172  0,102  Antineoplastic (glioblastoma multiforme)
0,194  0,124  Immunostimulant
0,209  0,139  CYP2D6 inhibitor
0,138  0,069  Antieczematic
0,069  0,002  Retinoid X beta receptor antagonist
0,070  0,003  Retinoid X alpha receptor antagonist
0,080  0,013  Lipocortins synthesis agonist
0,078  0,012  Mineralocorticoid receptor antagonist
0,171  0,106  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,070  0,007  Parathyroid hormone antagonist
0,094  0,030  Narcotic antagonist
0,127  0,064  Antiviral (Papilloma)
0,115  0,053  AMP-activated protein kinase stimulant
0,131  0,069  Acetylcholinesterase inhibitor
0,152  0,091  Liver fibrosis treatment
0,110  0,050  Antineoplastic, alkylator
0,081  0,021  Transcription factor AP-1 inhibitor
0,104  0,044  SULT1E1 substrate
0,063  0,004  Retinoid X beta receptor agonist
0,073  0,014  Potassium channel Kv1.3 blocker
0,079  0,022  Antihemophilic
0,119  0,062  Microtubule formation inhibitor
0,221  0,165  FMO1 substrate
0,260  0,206  Alzheimer's disease treatment
0,251  0,197  Antiarthritic
0,108  0,055  Butyrylcholinesterase inhibitor
0,085  0,032  Premenstrual syndrome treatment
0,055  0,004  Retinoic acid receptor antagonist
0,076  0,024  Hypercalcemia treatment
0,060  0,009  Retinoic acid alpha receptor agonist
0,102  0,051  Interleukin 12 antagonist
0,067  0,016  Estrogen receptor beta agonist
0,126  0,077  Skin whitener
0,057  0,009  Estradiol 17 beta-dehydrogenase 3 inhibitor
0,052  0,004  Retinoic acid alpha receptor antagonist
0,050  0,003  Retinoid X gamma receptor antagonist
0,091  0,045  Acetylcholine nicotinic antagonist
0,110  0,065  Skin irritative effect
0,052  0,007  Estrone sulfatase inhibitor
0,154  0,110  Antiviral (Hepatitis)
0,159  0,116  CYP2B6 inhibitor
0,139  0,098  Movement disorders treatment
0,066  0,025  Sigma receptor antagonist
0,059  0,019  Opioid kappa receptor agonist
0,055  0,016  Estrogen receptor alpha agonist
0,126  0,087  CC chemokine 6 receptor antagonist
0,165  0,127  Aldehyde oxidase inhibitor
0,133  0,095  Eye irritation, high
0,070  0,032  Antimycoplasmal
0,092  0,055  Opioid antagonist
0,046  0,009  ATP citrate lysase inhibitor
0,184  0,147  Amyotrophic lateral sclerosis treatment
0,078  0,041  Purinergic P2X2 antagonist
0,050  0,014  Heme oxygenase inhibitor
0,049  0,012  2,3-Oxidosqualene-lanosterol cyclase inhibitor
0,042  0,006  Retinoic acid receptor agonist
0,114  0,079  Antiseptic
0,039  0,004  NMDA receptor phencyclidine site antagonist
0,107  0,073  Interleukin 1b antagonist
0,047  0,014  Delayed rectifier potassium channel blocker
0,037  0,004  Retinoic acid gamma receptor agonist
0,057  0,025  Anesthetic inhalation
0,105  0,075  Acetylcholine release stimulant
0,107  0,076  Antitussive
0,087  0,057  Antileprosy
0,133  0,104  Ca2+-transporting ATPase inhibitor
0,108  0,079  Interleukin 8 antagonist
0,035  0,006  Hedgehog signaling activator
0,095  0,067  Tourette's syndrome treatment
0,047  0,020  Hypogonadism treatment
0,065  0,038  TRPA1 antagonist
0,157  0,130  Pneumotoxic
0,043  0,017  Glucose-6-phosphate dehydrogenase inhibitor
0,030  0,004  Retinoic acid beta receptor antagonist
0,030  0,004  Retinoic acid receptor gamma antagonist
0,043  0,017  Antihyperaldosteronism
0,059  0,033  Pregnane X receptor antagonist
0,040  0,014  HMG CoA reductase inhibitor
0,050  0,025  Estradiol 17 beta-dehydrogenase inhibitor
0,146  0,122  Antineoplastic (bone cancer)
0,126  0,102  Antidiabetic (type 1)
0,043  0,020  Cholesterol absorption inhibitor
0,099  0,078  GABA receptor agonist
0,169  0,147  Age-related macular degeneration treatment
0,027  0,006  Retinoic acid beta receptor agonist
0,082  0,061  GABA A receptor agonist
0,061  0,040  Bombesin 1 receptor agonist
0,029  0,008  Vitamin D receptor antagonist
0,117  0,096  Antianorexic
0,115  0,095  Antihemorrhagic
0,125  0,106  Urinary incontinence treatment
0,027  0,008  Progesterone agonist
0,036  0,018  Melatonin receptor 1A agonist
0,158  0,141  Antiviral (HIV)
0,066  0,049  Opioid mu receptor antagonist
0,170  0,154  Antihypotensive
0,155  0,139  Antineoplastic (lymphocytic leukemia)
0,170  0,156  Superoxide dismutase inhibitor
0,081  0,068  Vanilloid agonist
0,167  0,155  Cardiotonic
0,024  0,011  Corticosteroid-like
0,036  0,024  AMPA receptor agonist
0,059  0,047  NMDA 2C receptor antagonist
0,100  0,089  Beta amyloid protein antagonist
0,019  0,008  Glucocorticoid agonist
0,027  0,017  Nicotinic acid receptor 2 antagonist
0,071  0,061  Nicotinic alpha4beta2 receptor antagonist
0,107  0,099  Antismoking
0,013  0,006  3 Beta-hydroxy-delta 5-steroid dehydrogenase inhibitor
0,023  0,016  CYP24 inhibitor
0,161  0,154  Antidiabetic symptomatic
0,186  0,180  Immunomodulator
0,217  0,211  Antibacterial
0,058  0,052  Nitric oxide donor
0,130  0,124  Antiviral (Hepatitis C)
0,028  0,023  Complement C5a chemotactic receptor antagonist
0,028  0,022  Glucagon receptor antagonist
0,053  0,047  HIV-1 integrase (Strand Transfer) inhibitor
0,017  0,012  Telomerase stimulant
0,031  0,027  Carboxypeptidase B inhibitor
0,016  0,012  Vitamin D receptor agonist
0,018  0,015  Progesterone receptor B antagonist
0,009  0,006  Progesterone receptor A antagonist
0,069  0,066  Antineoplastic antibiotic
0,015  0,014  Thyroid hormone alpha agonist
0,074  0,073  Antidote, organophosphates
0,057  0,057  Antiemphysemic

